OPTIMIZERx Announces Sponsorship of the CBInet eRx and EHR Conference
20 März 2014 - 7:44PM
Marketwired
OPTIMIZERx Announces Sponsorship of the CBInet eRx and EHR
Conference
ROCHESTER, MI--(Marketwired - Mar 20, 2014) - OPTIMIZERx
Corp (OTCQB: OPRX) today announced that it is sponsoring the CBInet
eRx and EHR conference March 26 - 27 in Philadelphia, PA.
OPTIMIZERx is excited to be one of the lead Co-Sponsors for this
inaugural event. The conference is the first and only conference
dedicated entirely to strategies and tactics that leverage the
ever-growing utilization of e-prescribing and EHR technology and
focuses on leverage opportunities for promotional effectiveness and
brand awareness. The conference will be held at the Hyatt at the
Bellevue in Philadelphia, PA. Amongst the industry expert,
pharmaceutical presenters and discussion panel members, David
Harrell the Chairman and CEO of OPTIMIZERX will also be presenting
on leveraging technology to improve patient result and
outcomes.
"With the ever changing landscape and transformation of the
healthcare market, we are forging a new frontier for pharmaceutical
marketing and brand managers," said David Harrell, Chairman and CEO
of OPTIMIZERx Corporation, "by sponsoring this event we bring
together industry leading experts from manufacturers, healthcare
providers and solution suppliers in one forum to share experiences,
discuss issues, and collaborate to pave new roads to effectively
utilize these technologies that result in better patient
outcomes."
For more information and to register:
http://www.cbinet.com/conference/pc14028#.UwzmRPldWSo
OPTIMIZERx Corp. provides unique consumer and physician
platforms to help patients better afford and comply with their
medicines and healthcare products, while offering pharmaceutical
and healthcare companies effective ways to expand patient
awareness, access and adherence to their brands. For more
information, please go to www.optimizerxcorp.com.
'SAFE HARBOR'
This press release contains forward-looking statements within
the definition of Section 27A of the Securities Act of 1933, as
amended and such section 21E of the Securities Act of 1934,
amended. These forward-looking statements should not be used to
make an investment decision. The words 'estimate,' 'possible' and
'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise
any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or
underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government
regulation, competition and other material risks.
Contact: Ms. Gabrielle Sabatini Email Contact
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Sep 2024 bis Okt 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Okt 2023 bis Okt 2024